Literature DB >> 29273198

Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome.

Bárbara Echiburú1, Francisco Pérez-Bravo2, José E Galgani3, Daniel Sandoval4, Carolina Saldías4, Nicolás Crisosto5, Manuel Maliqueo5, Teresa Sir-Petermann5.   

Abstract

CONTEXT: Polycystic ovary syndrome (PCOS) is an androgen excess disorder associated with obesity and adipose tissue disturbances. Our aim was to evaluate gene expression of adipocytokines and adipocyte characteristics in abdominal subcutaneous adipose tissue (SAT) of PCOS women.
DESIGN: Twelve PCOS (PCOSw) and 12 control (Cw) premenopausal women (BMI 20-35 kg/m2) were included, with measurements of whole-body composition assessed by dual-energy X-ray absorptiometry, and abdominal subcutaneous and visceral adipose tissue (VAT) volume, by magnetic resonance imaging. An oral glucose tolerance test was performed with measurements of glucose and insulin, and sex steroids, lipid profile and serum adipocytokines were determined in the fasting sample. Adipocytokine gene expression, mean adipocyte area and macrophage infiltration were evaluated in SAT biopsies.
RESULTS: Both groups were comparable in age and BMI. Trunk fat mass amount (p = .043), serum and SAT leptin/adiponectin ratio (p = .034 and p = .028, respectively) and adipocyte area (p = .015) were higher in PCOSw compared to Cw. Interestingly, trunk fat mass was positively correlated with adipocyte area in PCOSw (r = 0.821, p = .023), while the inverse correlation was found in Cw (r = -0.786, p = .021). Only in PCOSw, adipocyte area was positively correlated with serum testosterone (r = 0.857, p = .014) and visceral adipose tissue volume (r = 0.857, p = .014).
CONCLUSIONS: Our results indicate that PCOS women present adipose tissue dysfunction in the subcutaneous compartment, characterized by an alteration in adipocyte size and leptin/adiponectin expression and secretion, probably associated with higher androgen concentrations.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipocytokines; Polycystic ovary syndrome; Subcutaneous adipose tissue

Mesh:

Substances:

Year:  2017        PMID: 29273198     DOI: 10.1016/j.steroids.2017.12.009

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  14 in total

1.  Heat therapy improves glucose tolerance and adipose tissue insulin signaling in polycystic ovary syndrome.

Authors:  Brett R Ely; Zachary S Clayton; Carrie E McCurdy; Joshua Pfeiffer; Karen Wiedenfeld Needham; Lindan N Comrada; Christopher T Minson
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-05-28       Impact factor: 4.310

2.  Prediction of Circulating Adipokine Levels Based on Body Fat Compartments and Adipose Tissue Gene Expression.

Authors:  Stefan Konigorski; Jürgen Janke; Dagmar Drogan; Manuela M Bergmann; Johannes Hierholzer; Rudolf Kaaks; Heiner Boeing; Tobias Pischon
Journal:  Obes Facts       Date:  2019-11-07       Impact factor: 3.942

3.  The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial.

Authors:  V Soldat-Stanković; S Popović-Pejičić; S Stanković; A Prtina; G Malešević; J Bjekić-Macut; S Livadas; S Ognjanović; G Mastorakos; D Micić; D Macut
Journal:  J Endocrinol Invest       Date:  2021-10-19       Impact factor: 4.256

4.  Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome.

Authors:  Büşra Başar Gökcen; Yasemin Akdevelioğlu; Sultan Canan; Nuray Bozkurt
Journal:  Eat Weight Disord       Date:  2020-08-08       Impact factor: 4.652

5.  Inhibition of Col6a5 Improve Lipid Metabolism Disorder in Dihydrotestosterone-Induced Hyperandrogenic Mice.

Authors:  Li-Feng Sun; Ya-Li Yang; Mei-Yue Wang; Hua-Shan Zhao; Tian-Xia Xiao; Meng-Xia Li; Bao-Bei Wang; Chen Huang; Pei-Gen Ren; Jian V Zhang
Journal:  Front Cell Dev Biol       Date:  2021-05-24

6.  Increased Adipose Tissue Indices of Androgen Catabolism and Aromatization in Women With Metabolic Dysfunction.

Authors:  Giada Ostinelli; Sofia Laforest; Scott G Denham; Marie-Frederique Gauthier; Virginie Drolet-Labelle; Emma Scott; Frédéric-Simon Hould; Simon Marceau; Natalie Z M Homer; Catherine Bégin; Ruth Andrew; André Tchernof
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

7.  Lower circulating levels of CTRP12 and CTRP13 in polycystic ovarian syndrome: Irrespective of obesity.

Authors:  Mehrnoosh Shanaki; Nariman Moradi; Reza Fadaei; Zahra Zandieh; Parisa Shabani; Akram Vatannejad
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

8.  Body Composition and Characterization of Skinfold Thicknesses from Polycystic Ovary Syndrome Phenotypes. A Preliminar Case-Control Study.

Authors:  María L Sánchez-Ferrer; Ernesto De La Cruz-Sánchez; Julián J Arense-Gonzalo; María T Prieto-Sánchez; Itziar Bernabeu-González; Ana Carmona-Barnosi; Jaime Mendiola; Alberto M Torres-Cantero
Journal:  Int J Environ Res Public Health       Date:  2021-03-14       Impact factor: 3.390

9.  Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.

Authors:  Miguel A Sanchez-Garrido; Manuel Tena-Sempere
Journal:  Mol Metab       Date:  2020-02-05       Impact factor: 7.422

10.  Fat Cell Size: Measurement Methods, Pathophysiological Origins, and Relationships With Metabolic Dysregulations.

Authors:  Run Zhou Ye; Gabriel Richard; Nicolas Gévry; André Tchernof; André C Carpentier
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.